ES8607357A1 - Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar - Google Patents

Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar

Info

Publication number
ES8607357A1
ES8607357A1 ES535923A ES535923A ES8607357A1 ES 8607357 A1 ES8607357 A1 ES 8607357A1 ES 535923 A ES535923 A ES 535923A ES 535923 A ES535923 A ES 535923A ES 8607357 A1 ES8607357 A1 ES 8607357A1
Authority
ES
Spain
Prior art keywords
microphase separated
controlled release
bioactive materials
blend
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535923A
Other languages
English (en)
Other versions
ES535923A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kendall Co
Original Assignee
Kendall Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kendall Co filed Critical Kendall Co
Publication of ES8607357A1 publication Critical patent/ES8607357A1/es
Publication of ES535923A0 publication Critical patent/ES535923A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
    • C08L39/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L57/00—Compositions of unspecified polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE FABRICACION DE UN GEL QUE LIBERA CONTROLADAMENTE AGENTES FARMACOLOGICOS. COMPRENDE: A) DISOLVER UN MATERIAL BIOACTIVO LIBERABLE, JUNTO CON UN COMPONENTE POLIMERO NO RETICULADO SOLUBLE EN AGUA Y UN COPOLIMERO NO RETICULADO INSOLUBLE EN AGUA, EN UN DISOLVENTE ELEGIDO ENTRE 2-METOXIETANOL, N, N-DIMETILFORMAMIDA Y METANOL; B) SEPARAR EL DISOLVENTE POR EVAPORACION, BAJO VACIO A UNA TEMPERATURA COMPRENDIDA ENTRE 60 Y 100JC; Y C) TRANSFORMAR LA MEZCLA DE HIDROGEL ASI FORMULADA, MEDIANTE EXTRUSION DE MASA FUNDIDA, MOLDEO, O COLADA EN SOLUCION, EN UN DISPOSITIVO DE LIBERACION CONTROLADA DE MATERIALES BIOACTIVOS EN EL QUE DICHOS COMPONENTES POLIMEROS, SOLUBLE EN AGUA E INSOLUBLE EN AGUA, Y DICHO MATERIAL BIOACTIVO LIBERABLE QUEDAN DISPERSOS POR TODAS PARTES SEGUN UNA MORFOLOGIA DE DOMINIOS DE MICROFASES. SIENDO: EL POLIMERO HIDROSOLUBLE, HOMOPOLIMERO DE N-VINIL-LACTAMA; Y EL INSOLUBLE, UN 50-90% EN PESO DE UN MONOMERO ETILINICAMENTE INSATURADO, UN 2-12% DE UN MONOMERO SIN GRUPOS ACIDOS E HIDROFILO. SE UTILIZA EN FARMACOLOGIA PARA APLICAR DOSIS DE EFECTO SUAVE Y CONTINUADO.
ES535923A 1983-09-15 1984-09-14 Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar Expired ES8607357A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53264383A 1983-09-15 1983-09-15
US06/606,794 US4693887A (en) 1983-09-15 1984-05-03 Microphase separated hydrogels for controlled release of bioactive materials

Publications (2)

Publication Number Publication Date
ES8607357A1 true ES8607357A1 (es) 1986-05-16
ES535923A0 ES535923A0 (es) 1986-05-16

Family

ID=27063895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535923A Expired ES8607357A1 (es) 1983-09-15 1984-09-14 Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar

Country Status (18)

Country Link
US (1) US4693887A (es)
AT (1) ATA290884A (es)
AU (1) AU577056B2 (es)
BE (1) BE900581A (es)
BR (1) BR8404409A (es)
CA (1) CA1232201A (es)
CH (1) CH666415A5 (es)
DE (1) DE3432573A1 (es)
DK (1) DK410984A (es)
ES (1) ES8607357A1 (es)
FR (1) FR2551976B1 (es)
GB (2) GB2147002B (es)
IT (1) IT1178430B (es)
NL (1) NL8402833A (es)
NO (1) NO843650L (es)
NZ (1) NZ209323A (es)
PT (1) PT79192B (es)
SE (1) SE461502B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2062900A1 (es) * 1991-07-29 1994-12-16 Univ Madrid Nac Educacion Hidrogeles de polimero heterociclico, su procedimiento de obtencion y su utilizacion como pastillas insolubles reguladoras del ph.

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
DE3517080A1 (de) * 1985-05-11 1986-11-13 Bayer Ag, 5090 Leverkusen Komponente fuer therapeutische wirkstoffabgabesysteme
IE59361B1 (en) * 1986-01-24 1994-02-09 Akzo Nv Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
US4867969A (en) * 1986-02-07 1989-09-19 Alza Corporation Hydrogel formulation for administering non-steroidal drugs
US4971790A (en) * 1986-02-07 1990-11-20 Alza Corporation Dosage form for lessening irritation of mocusa
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5133992A (en) * 1988-03-21 1992-07-28 Eastman Kodak Company Colloidally stabilized suspension process
US4931287A (en) * 1988-06-14 1990-06-05 University Of Utah Heterogeneous interpenetrating polymer networks for the controlled release of drugs
EP0347145A3 (en) * 1988-06-14 1990-10-24 University Of Utah Research Foundation Heterogeneous interpenetrating polymer networks for the controlled release of drugs
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5270358A (en) * 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
AU662582B2 (en) * 1991-11-15 1995-09-07 Minnesota Mining And Manufacturing Company Biomedical electrode provided with two-phase composites conductive, pressure-sensitive adhesive
US5352448A (en) * 1992-07-20 1994-10-04 Purdue Research Foundatioin Oral administration of antigens
EP0605705B1 (en) * 1992-07-29 1997-05-21 Baxter International Inc. Pharmaceutical containers and medical devices with hydrophilic protein-compatible surfaces
DE4341156C2 (de) * 1993-12-02 1997-11-13 Wacker Chemie Gmbh Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
US5840338A (en) * 1994-07-18 1998-11-24 Roos; Eric J. Loading of biologically active solutes into polymer gels
DE19622355A1 (de) * 1996-06-04 1997-12-11 Bayer Ag Formkörper die agrochemische Mittel freisetzen
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
US8003705B2 (en) 1996-09-23 2011-08-23 Incept Llc Biocompatible hydrogels made with small molecule precursors
US6566406B1 (en) 1998-12-04 2003-05-20 Incept, Llc Biocompatible crosslinked polymers
US5814329A (en) * 1996-11-12 1998-09-29 Polytherapeutics, Inc. Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
DE19753298A1 (de) * 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
AU760408B2 (en) 1998-04-27 2003-05-15 Surmodics, Inc. Bioactive agent release coating
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
DE60327752D1 (de) 2002-03-14 2009-07-09 Medrx Co Ltd Topisches medikament für wunden
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US20040111144A1 (en) * 2002-12-06 2004-06-10 Lawin Laurie R. Barriers for polymeric coatings
WO2005003192A1 (en) * 2003-06-26 2005-01-13 Symyx Technologies, Inc. Synthesis of photoresist polymers
WO2005027864A1 (en) * 2003-09-19 2005-03-31 Symyx Technologies, Inc. Materials for enhanced delivery of hydrophilic active agents in personal care formulations
CN1964748A (zh) 2004-04-06 2007-05-16 苏莫迪克斯公司 用于生物活性剂的涂料组合物
US8148560B2 (en) * 2005-09-23 2012-04-03 Teva Women's Health, Inc. Vaginal tablets comprising misoprostol and methods of making and using the same
JP5367692B2 (ja) * 2006-02-08 2013-12-11 タイレックス・インコーポレイテッド 一時的補剛メッシュ補綴具
US20080187568A1 (en) * 2007-02-06 2008-08-07 Sawhney Amarpreet S Polymerization with precipitation of proteins for elution in physiological solution
CN201075472Y (zh) * 2007-05-28 2008-06-18 富士康(昆山)电脑接插件有限公司 电连接器
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
US8745133B2 (en) * 2008-03-28 2014-06-03 Yahoo! Inc. System and method for optimizing the storage of data
JP5890182B2 (ja) * 2009-02-12 2016-03-22 インセプト エルエルシー ヒドロゲルプラグによる薬物送達
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085168A (en) * 1971-02-22 1978-04-18 Cpc International Inc. Chemically joined, phase separated self-cured hydrophilic thermoplastic graft copolymers and their preparation
US4277582A (en) * 1978-03-03 1981-07-07 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers
SU806037A1 (ru) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Антиангинальное средство
SE448544B (sv) * 1979-12-05 1987-03-02 Kendall & Co Vattenabsorberande komposition och anvendning derav som berare for ett lekemedel
SU1243627A3 (ru) * 1979-12-05 1986-07-07 Дзе Кендалл Компани (Фирма) Гелеобразующа композици
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4423099A (en) * 1980-07-28 1983-12-27 Ciba-Geigy Corporation Membrane modified hydrogels
JPS5776046A (en) * 1980-10-27 1982-05-12 Kendall & Co Water absorbing composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2062900A1 (es) * 1991-07-29 1994-12-16 Univ Madrid Nac Educacion Hidrogeles de polimero heterociclico, su procedimiento de obtencion y su utilizacion como pastillas insolubles reguladoras del ph.

Also Published As

Publication number Publication date
ATA290884A (de) 1991-07-15
CH666415A5 (de) 1988-07-29
BR8404409A (pt) 1985-07-30
GB2177708A (en) 1987-01-28
ES535923A0 (es) 1986-05-16
SE8404568L (sv) 1985-03-16
GB8423416D0 (en) 1984-10-24
FR2551976B1 (fr) 1988-06-10
SE8404568D0 (sv) 1984-09-12
DK410984D0 (da) 1984-08-28
US4693887A (en) 1987-09-15
PT79192A (en) 1984-10-01
BE900581A (fr) 1985-03-14
SE461502B (sv) 1990-02-26
DK410984A (da) 1985-03-16
AU3226884A (en) 1985-03-21
NZ209323A (en) 1987-04-30
NO843650L (no) 1985-03-18
NL8402833A (nl) 1985-04-01
AU577056B2 (en) 1988-09-15
GB2147002B (en) 1987-11-11
DE3432573A1 (de) 1985-04-18
PT79192B (en) 1986-08-14
FR2551976A1 (fr) 1985-03-22
IT8448836A1 (it) 1986-03-13
GB8620117D0 (en) 1986-10-01
CA1232201A (en) 1988-02-02
GB2147002A (en) 1985-05-01
IT1178430B (it) 1987-09-09
IT8448836A0 (it) 1984-09-13

Similar Documents

Publication Publication Date Title
SE8404568D0 (sv) Microphase separated hydrogels for controlled release of bioactive materials
US4140162A (en) Clear, autoclavable plastic formulation free of liquid plasticizers
US4968317B1 (en) Surgical materials and devices
EG20321A (en) Medical material and process for producing the same
CA2203901A1 (en) Polymeric wound healing accelerators
IL68426A (en) Biodegradable amphipathic block copolymers,their preparation and continuous release pharmaceutical and veterinary compositions comprising them
EP0162026A3 (en) A bacteria adsorbing composition
EP0324278A3 (en) Process for preparing thermoplastic resin composition
NZ506415A (en) Liquid polymeric compositions for controlled release of bioactive substances using a polymer to active agent ratio of less than 1:1
MX9706626A (es) Composiciones farmaceuticas para la liberacion controlada de receptores solubles.
CA2161903A1 (en) Polymer Composition, Absorbent Material Composition, Their Production and Use
DE3776776D1 (de) Polymerlatex mit ultrafeinen teilchen und diesen enthaltende zusammensetzungen.
GR3017267T3 (en) Antiacid compositions with prolonged gastric residence time.
IE46085L (en) Delivery means for bioactive agents
AU651615B2 (en) Polymeric blends containing a block poly (ether-co-amide)
IL115138A (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
EP0272562A3 (en) Basic adhesive polymeric mass transmitting the active ingredient, method for making it and its use
CA2265788A1 (en) Thermoplastic polyurethanes containing active substances
CA2133955A1 (en) Polyetheramidoamine hydrogels as heparinizable materials
GR3026551T3 (en) Composition of polymers for medical applications.
EP0480391A3 (en) Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions
ES554593A0 (es) Procedimiento para la preparacion de una composicion de liberacion retardada y controlada.
EP0138784A3 (en) Arabinogalactans, their preparation and compositions containing same
ZA821613B (en) Polymeric material containing randomly distributed hydroxyl groups from polymers and copolymers of conjugated dienes,process for the preparation thereof,and use thereof
TH23079A (th) วัสดุทางการแพทย์ และขบวนการสำหรับการผลิตสิ่งนั้น

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990201